Kazuki Tomura

1PUBLICATIONS
2CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Nov 20, 2024
Cost-effectiveness analysis of first line pembrolizumab monotherapy for high programmed cell death ligand 1 expressed, advanced non-small cell lung cancer in Japan.

Kazuki Tomura, Hiroyuki Sakamaki, Shuichi Nawata

Pageof 1

Frequent Collaborators

1 joint publications

Shuichi Nawata

1 joint publications

Mari Kogo